Journal article

Comparison of mRNA Splicing Assay Protocols across Multiple Laboratories: Recommendations for Best Practice in Standardized Clinical Testing

Phillip J Whiley, Miguel de la Hoya, Mads Thomassen, Alexandra Becker, Rita Brandao, Inge Sokilde Pedersen, Marco Montagna, Mireia Menendez, Francisco Quiles, Sara Gutierrez-Enriquez, Kim De Leeneer, Anna Tenes, Gemma Montalban, Demis Tserpelis, Toshio Yoshimatsu, Carole Tirapo, Michela Raponi, Trinidad Caldes, Ana Blanco, Marta Santamarina Show all

Clinical Chemistry: international journal of molecular diagnostics and laboratory medicine | AMER ASSOC CLINICAL CHEMISTRY | Published : 2014

Grants

Awarded by National Breast Cancer Foundation and Cancer Australia


Awarded by National Cancer Institute


Awarded by Australian NHMRC Project


Awarded by Spanish Association Against Cancer


Awarded by Italian Association for Cancer Research (AIRC)


Awarded by Xunta de Galicia


Awarded by Fondo de Investigacion Sanitaria (FIS)


Awarded by Spanish Carlos III Health Institute - Miguel Servet Project


Awarded by Spanish Carlos III Health Institute


Funding Acknowledgements

The Clinical Follow Up Study was funded 20012009 by NHMRCand currently by the National Breast Cancer Foundation and Cancer Australia #628333. kConFab is supported by grants from the National Breast Cancer Foundation, the National Health and Medical Research Council (NHMRC) and by the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. The Beckman Research Institute of City of Hope (BRICOH) study was supported by Grant Number P30 CA033572 from the National Cancer Institute. R. Brandao, Fundac, a opara a Ciencia e Tecnologia; A. B. Spurdle, Australian NHMRC Project grant ID #1010719, The University of Queensland, NHMRC Senior Research Fellowship; M. A. Brown, Australian NHMRC Project grant ID #1010719, The University of Queensland; C. Lazaro, the Spanish Health Research Fund, Carlos III Health Institute, Catalan Health Institute, Government of Catalonia and the Spanish Association Against Cancer (Contract grant numbers: ISCIIIRETIC: RD06/0020/1051, 2009SGR290, PI10/01422); C. Houdayer, INCA DHOS 2010 Recherche Translationnelle sur le Cancer, FASDEC grant; L. C. Walker, Health Research Council NZ Sir Charles Hercus Health Research Fellowship; D. Baralle, CRUK Project grant; M. Colombo, the Italian Association for Cancer Research (AIRC; grant number 11897); G. De Vecchi, the Italian Association for Cancer Research (AIRC; grant number 11897); P. Radice, the Italian Association for Cancer Research (AIRC; grant number 11897); M. de la Hoya, the NEYE Foundation, the Xunta de Galicia (10PXIB 9101297PR) and FMM Foundation and a Fondo de Investigacion Sanitaria (FIS) research grant PI 12/00539, an initiative of the Insituto de Salud Carlos III (Spain), partially supported by European Regional; S. Gutierrez-Enriquez, Miguel Servet contract from the Spanish Carlos III Health Institute - Miguel Servet Project grant CP10/00617; A. Tenes, Miguel Servet contract from the Spanish Carlos III Health Institute; A. Vega, Xunta de Galicia, FMM Foundation; O. Diez, Fondo de Investigacion Sanitaria (FIS) research grant PI 12/02585 from the Spanish Carlos III Health Institute.